课题基金 / 基金详情

Deferiprone to Delay Dementia (The 3D study)

Deferiprone to Delay Dementia (The 3D study)
去铁酮可延缓痴呆(3D 研究)
批准号:
nhmrc : GNT1123625
负责人:
A/Pr Kathryn Ellis
金额:
$185.5万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

A/Pr Kathryn Ellis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There are currently no drugs available to prevent or slow deterioration in Alzheimer’s disease – which is a major incurable dementia. Our recent findings demonstrate that high brain iron levels worsen brain performance and cause people to develop Alzheimer’s disease at an earlier point in time. We propose a clinical trial of deferiprone, a drug that lowers brain iron levels, to determine if this would slow deterioration in Alzheimer’s disease once it is first detected.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Centre of Research Excellence in Cognitive Health: Evidence, intervention and population modelling
  • 批准号:
    nhmrc : GNT1100579
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $249.99万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Kathryn Ellis
  • 依托单位:
海外基金